Science 37 Sees FY23 Adjusted EBITDA Loss Of Approximately $(32.5)M Versus Prior Guidance Of Approximately $(35.0)M
Portfolio Pulse from Benzinga Newsdesk
Science 37 has updated its FY23 guidance, expecting an adjusted EBITDA loss of approximately $32.5 million, an improvement from the previously anticipated loss of $35 million.
November 07, 2023 | 11:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Science 37's revised FY23 guidance indicates a smaller EBITDA loss than previously expected, which could be seen as a positive sign by investors.
The company's revised guidance indicates an improvement in its financial performance, which could potentially lead to a positive reaction from the market. However, the company is still expected to post a significant EBITDA loss, which investors should take into account.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100